Barclays’s Cascadian Therapeutics, Inc. CASC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-6,125
| Closed | -$23K | – | 4561 |
|
|
2017
Q4 | $23K | Sell |
6,125
-8,875
| -59% | -$33.3K | ﹤0.01% | 3671 |
|
|
2017
Q3 | $61K | Buy |
15,000
+14,969
| +48,287% | +$60.9K | ﹤0.01% | 2871 |
|
|
2017
Q2 | $0 | Sell |
31
-29,133
| -100% | – | ﹤0.01% | 4263 |
|
|
2017
Q1 | $120K | Buy |
29,164
+27,172
| +1,364% | +$112K | ﹤0.01% | 2762 |
|
|
2016
Q4 | $9K | Buy |
1,992
+1,523
| +325% | +$6.88K | ﹤0.01% | 3310 |
|
|
2016
Q3 | $5K | Sell |
469
-3,258
| -87% | -$34.7K | ﹤0.01% | 3437 |
|
|
2016
Q2 | $21K | Buy |
3,727
+2,120
| +132% | +$11.9K | ﹤0.01% | 2809 |
|
|
2016
Q1 | $9K | Buy |
1,607
+1,140
| +244% | +$6.39K | ﹤0.01% | 2964 |
|
|
2015
Q4 | $6K | Buy |
467
+384
| +463% | +$4.93K | ﹤0.01% | 2895 |
|
|
2015
Q3 | $1K | Sell |
83
-4,036
| -98% | -$48.6K | ﹤0.01% | 3873 |
|
|
2015
Q2 | $73K | Buy |
4,119
+2,697
| +190% | +$47.8K | ﹤0.01% | 2488 |
|
|
2015
Q1 | $9K | Buy |
1,422
+323
| +29% | +$2.04K | ﹤0.01% | 3452 |
|
|
2014
Q4 | $7K | Sell |
1,099
-1,264
| -53% | -$8.05K | ﹤0.01% | 3886 |
|
|
2014
Q3 | $14K | Buy |
2,363
+229
| +11% | +$1.36K | ﹤0.01% | 3598 |
|
|
2014
Q2 | $39K | Sell |
2,134
-47
| -2% | -$859 | ﹤0.01% | 3155 |
|
|
2014
Q1 | $26K | Buy |
2,181
+1,256
| +136% | +$15K | ﹤0.01% | 3472 |
|
|
2013
Q4 | $5K | Buy |
925
+661
| +250% | +$3.57K | ﹤0.01% | 4057 |
|
|
2013
Q3 | $3K | Sell |
264
-13,066
| -98% | -$148K | ﹤0.01% | 3924 |
|
|
2013
Q2 | $126K | Buy |
+13,330
| New | +$126K | ﹤0.01% | 2924 |
|